Postpericardiotomy Syndrome in an Infant with Down Syndrome Presenting with Recurrent Pericardial Effusion
    PDF
    Cite
    Share
    Request
    Case Report
    P: 53-56
    April 2023

    Postpericardiotomy Syndrome in an Infant with Down Syndrome Presenting with Recurrent Pericardial Effusion

    J Pediatr Emerg Intensive Care Med 2023;10(1):53-56
    1. University of Health Sciences Turkey, Ankara Sami Ulus Gynecology, Child Health and Diseases Hospital, Clinic of Pediatric Intensive Care Unit, Ankara, Turkey
    2. University of Health Sciences Turkey, Ankara Sami Ulus Gynecology, Child Health and Diseases Hospital, Clinic of Pediatric Cardiology, Ankara, Turkey
    3. University of Health Sciences Turkey, Ankara Sami Ulus Gynecology, Child Health and Diseases Hospital Clinic of Pediatric Cardiovascular Surgery, Ankara, Turkey
    No information available.
    No information available
    Received Date: 03.12.2021
    Accepted Date: 17.03.2022
    Publish Date: 09.03.2023
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Postpericardiotomy syndrome (PPS) is a hypersensitivity reaction characterized by inflammation in pleural, pericardial or lung tissue following cardiac surgery or myocardial infarction. Clinically; fever, chest pain, findings related to pleural or pericardial effusion may be seen. In this case report, we wanted to present a case of Down syndrome who was followed up with PPS causing recurrent pericardial effusion after cardiac surgery for 5 months and was successfully treated by opening a pericardial window. PPS is one of the leading causes of post-cardiac morbidity in developed countries, despite all the advances in diagnosis and treatment. The earliest clinical finding is the development of pericardial effusion after the operation. Although pericardiocentesis is performed many times, PPS should be kept in mind in patients with recurrent pericardial effusion, and pericardial window opening should be considered in the treatment.

    Keywords: Postpericardiotomy syndrome, pericardial effusion, recurrent effusion

    Introduction

    Postpericardiotomy syndrome is also defined as postacute myocardial syndrome or post cardiac injury syndrome. Postpericardiotomy syndrome is a clinical picture characterized by fever, pleuropericarditis and parenchymal infiltration, which develops within weeks following pericardial and/or myocardial injury. This syndrome has been described in the literature after myocardial infarction, cardiac surgery, blunt chest trauma, pacemaker implantation, coronary stent implantation, heart punctures and angioplasty.1

    Although the exact etiology of the syndrome is not known, it is accepted that it is an immune event caused by autoantibodies formed against antigens released after pericardial damage.2

    Pericardial effusion is defined as an increase in fluid between the pericardial leaves. Various factors play a role in the etiology. Tuberculosis (primary cause especially in developing countries), viral infections and postoperative complications may cause effusion.3

    In this study, we wanted to present a case of postpericardiotomy syndrome, which caused recurrent pericardial effusion resistant to medical treatment after cardiac surgery and required 4 pericardiocentesis and interventional tube insertion, with clinical and radiological findings.

    Case Report

    It was learned from the history of the patient, who was diagnosed with complete atrioventricular septal defect for the first time at the age of 4 months, that the patient was born prematurely, had Down syndrome, had body weight below the 3rd percentile in the follow-ups, and received thyroid hormone LT4 replacement therapy due to hypothyroidism. Since the atrioventricular valve structure was not suitable for full correction, pulmonary banding surgery was performed 2 weeks after the diagnosis.

    A pericardial effusion of 11 mm was detected in the patient who applied to the outpatient clinic with respiratory distress 14 days after discharge. The patient was admitted to the pediatric cardiology service and methylprednisolone, furosemide and angiotensin converting enzyme inhibitor treatments were started.

    The patient’s blood tests taken at the time of hospitalization were as follows: White blood cell: 5400/mm3, polymorphonuclear cell count: 2180/mm3, hemoglobin: 11.2 g/dL, C-reactive protein: 4.9 mg/L, albumin: 3.1 g/dL, serum electrolytes: normal. Considering that the etiology of the effusion might be hypothyroidism, the patient’s current drug treatment was continued, since the thyroid function test results were between normal intervals, as T4: 1.4 ng/dL and thyroid-stimulating hormone: 4.9 ng/dL. During the follow-up, the patient’s pericardial effusion increased and respiratory distress occurred despite the treatment, and the patient’s effusion was drained with an appropriate technique. After the procedure, it was determined with echocardiography that the effusion was not present and the condition of the patient was improved. When it was determined that the pericardial effusion increased to 7 mm on the 4th day following the procedure, ibuprofen was started at a dose of 10 mg/kg/day in addition to the steroid. Ten days after the first pericardiocentesis, the patient had tachycardia and tachypnea, and pericardiocentesis was performed for the second time, as a 14.5 mm effusion was observed on echocardiography. When tachycardia (170-180/min) and tachypnea developed during the follow-up of the patient, echocardiography was repeated. Since pericardial fluid did not impair ventricular functions on echocardiography, 55 mL of serous fluid was drained with pericardiocentesis for the third time. Pericardial fluid was in the nature of transudate, as in the first pericardiocentesis (Table 1). Thyroid function tests, metabolic tests, and immunological tests, which were ordered for etiology, were found to be normal. The bone marrow examination was normal in terms of malignancy in the patient, and no malignant cells were seen in the pericardial fluid cytology.

    Table 1

    As the patient’s respiratory distress continued, he was transferred to the intensive care unit. During the intensive care follow-ups, effusion was drained for the 4th time by puncture in the patient who developed tamponade clinic on the 10th day. There was no growth in the culture, gram staining was negative (Figure 1a, 1b). After clinically relieved patient re-developed effusion, a pigtail catheter with a 3F intraducer sheath was placed to drain the effusion permanently. Pericardial window was opened because the patient had repeated pericardiocentesis procedures for 4 times in total and effusion did not improve despite the medical treatment given (Figure 2). The patient was discharged asymptomatically on the 13th day of hospitalization.

    Figure 1a
    Figure 1b
    Figure 2

    Discussion

    Postpericardiotomy syndrome is characterized by fever, chest pain, pericarditis, pleuritis and pneumonia, which usually occur after cardiac trauma.4 Symptoms are observed in the first 3 weeks after cardiac operations. The two main symptoms of the syndrome are fever and chest pain.5 Chest pain in infants can manifest itself as irritability. Almost all cases have pericardial friction rub and most of them have pericardial effusion.6

    Systemic fluid retention, hepatomegaly, and hypoxemia may be observed. Laboratory examination usually reveals 10-20 thousand leukocytosis and moderately increased sedimentation rate.7

    Some criteria are used in the diagnosis of postpericardiotomy syndrome. These are classified as major and minor criteria. Major criteria include the presence of pericardial or pleural friction rub, chest pain and fever over 38 degrees. The minor criteria include an increase in erythrocyte sedimentation rate, C-reactive protein level and leukocyte count. It is stated that the presence of two major and one minor criteria is sufficient for diagnosis after excluding the conditions such as pneumonia, heart failure, pulmonary embolism etc.8

    Although postpericardiotomy syndrome has a self-limiting course in most cases, it carries a potential risk for cardiac tamponade due to the rapid accumulation of pericardial fluid. Pericardiocentesis may be required, although it is not common, in the course of the disease. Although late recurrence may be seen, it is very rare. There is almost no data on this syndrome in childhood. In studies conducted to date, the presence of surgical trauma and autoimmune pathogenesis has been blamed as risk factors in the development of the disease.8 Today, thanks to the developing intensive care units and advanced surgical techniques, the chance of complete surgical correction for congenital heart diseases has increased, which has also increased the incidence of postpericardiotomy syndrome. For this reason, it is very important to know the risk factor or factors for the development of postpericardiotomy syndrome, to prevent complications such as tamponade with close follow-up, early diagnosis and treatment in order to prevent the development of serious complications such as pericardial tamponade in patients with risk factors.1

    For the reason for the development of pericardial effusion in our patient, it was thought that the patient had postpericardiotomy syndrome, considering the presence of subfebrile fever, irritability, and high acute phase reactants under ibuprofen in the first 3 weeks after the pulmonary banding operation. In addition, the presence of underlying hypothyroidism due to Down syndrome facilitated the development of pericardial effusion.

    This syndrome should be considered in patients with recurrent pericardial effusion and congenital heart surgery, and rapid intervention is required to shorten the length of stay in the pediatric intensive care unit.

    Ethics

    Informed Consent: Verbal consent was obtained from the patient’s family.

    Peer-review: Externally peer-reviewed.

    Authorship Contributions

    Concept: Ş.K., M.U.Y., Design: Ş.K., U.A.Ö., Analysis or Interpretation: Ş.K, M.U.Y., U.A.Ö., M.T., Literature Search: Ş.K., M.U.Y., Writing: Ş.K.

    Conflict of Interest: No conflict of interest was declared by the authors.

    Financial Disclosure: The authors declared that this study received no financial support.

    References

    1
    Allen HD, Driscol DJ, Shaddy RE, Feltes T. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents 2012;2:1290-9.
    2
    Hearne C, Forjuoh SN. Postcardiac injury syndrome after coronary angioplasty and stenting. J Am Board Fam Pract. 2003;16:73-4.
    3
    Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749-54.
    4
    Nielsen SL, Nielsen FE. Post cardiac injury syndrome [Postcardiac injury syndrome]. Ugeskr Laeger. 1991;153:924-6.
    5
    Khan AH. The postcardiac injury syndromes. Clin Cardiol. 1992;15:67-72.
    6
    Wessman DE, Stafford CM. The postcardiac injury syndrome: case report and review of the literature. South Med J. 2006;99:309-14.
    7
    Madsen SM, Jakobsen TJ. Kolkicinbehandling af recidiverende "steroidafhaengig" pericarditis hos en patient med postmyokardieinfarktsyndrom (Dressler's syndrom) [Colchicine treatment of recurrent steroid-dependent pericarditis in a patient with post-myocardial-infarction syndrome (Dressler's syndrome)]. Ugeskr Laeger. 1992;154:3427-8.
    8
    Ashikhmina EA, Schaff HV, Sinak LJ, Li Z, Dearani JA, et al. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management. Ann Thorac Surg. 2010;89:112-8.
    2024 ©️ Galenos Publishing House